{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:20:22Z","timestamp":1785320422424,"version":"3.55.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00415-021-10809-x","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T16:02:31Z","timestamp":1631980951000},"page":"758-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Unexpected (123I)FP-CIT SPECT findings: SWIDD, SWEDD and all DAT"],"prefix":"10.1007","volume":"269","author":[{"given":"Balestrino","family":"Roberta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barone","family":"Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-0479","authenticated-orcid":false,"given":"Filippi","family":"Massimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erro","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,18]]},"reference":[{"key":"10809_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"10809_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Gaetani L, Eusebi P et al (2019) CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol 18:573\u2013586. https:\/\/doi.org\/10.1016\/S1474-4422(19)30024-9","journal-title":"Lancet Neurol"},{"key":"10809_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/ene.13269","volume":"24","author":"SP Caminiti","year":"2017","unstructured":"Caminiti SP, Alongi P, Majno L et al (2017) Evaluation of an optimized [18F]fluoro-deoxy-glucose positron emission tomography voxel-wise method to early support differential diagnosis in atypical Parkinsonian disorders. Eur J Neurol 24:687-e26. https:\/\/doi.org\/10.1111\/ene.13269","journal-title":"Eur J Neurol"},{"key":"10809_CR4","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1212\/WNL.0000000000005161","volume":"90","author":"A Pilotto","year":"2018","unstructured":"Pilotto A, Premi E, Paola Caminiti S et al (2018) Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease. Neurology 90:e1029\u2013e1037. https:\/\/doi.org\/10.1212\/WNL.0000000000005161","journal-title":"Neurology"},{"key":"10809_CR5","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1212\/WNL.0b013e31826c1b0a","volume":"79","author":"S Hellwig","year":"2012","unstructured":"Hellwig S, Amtage F, Kreft A et al (2012) [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology 79:1314\u20131322. https:\/\/doi.org\/10.1212\/WNL.0b013e31826c1b0a","journal-title":"Neurology"},{"key":"10809_CR6","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","volume":"47","author":"S Morbelli","year":"2020","unstructured":"Morbelli S, Esposito G, Arbizu J et al (2020) EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0. Eur J Nucl Med Mol Imaging 47:1885\u20131912. https:\/\/doi.org\/10.1007\/s00259-020-04817-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10809_CR7","volume-title":"Molecular imaging and contrast agent database (MICAD)","author":"K Leung","year":"2004","unstructured":"Leung K (2004) N-(3-Fluoropropyl)-2\u03b2-carbomethoxy-3\u03b2-(4-[123I]iodophenyl)nortropane. Molecular imaging and contrast agent database (MICAD). National Center for Biotechnology Information (US), Bethesda (MD)"},{"key":"10809_CR8","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1093\/brain\/aws211","volume":"135","author":"SJ Colloby","year":"2012","unstructured":"Colloby SJ, McParland S, O\u2019Brien JT, Attems J (2012) Neuropathological correlates of dopaminergic imaging in Alzheimer\u2019s disease and Lewy body dementias. Brain J Neurol 135:2798\u20132808. https:\/\/doi.org\/10.1093\/brain\/aws211","journal-title":"Brain J Neurol"},{"key":"10809_CR9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/mds.25975","volume":"29","author":"J Kraemmer","year":"2014","unstructured":"Kraemmer J, Kovacs GG, Perju-Dumbrava L et al (2014) Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts. Mov Disord 29:1767\u20131773. https:\/\/doi.org\/10.1002\/mds.25975","journal-title":"Mov Disord"},{"key":"10809_CR10","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1002\/mds.27777","volume":"34","author":"EA Honkanen","year":"2019","unstructured":"Honkanen EA, Saari L, Orte K et al (2019) No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson\u2019s disease. Mov Disord 34:1562\u20131566. https:\/\/doi.org\/10.1002\/mds.27777","journal-title":"Mov Disord"},{"key":"10809_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1212\/WNL.0000000000003810","volume":"88","author":"L Saari","year":"2017","unstructured":"Saari L, Kivinen K, Gardberg M et al (2017) Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease. Neurology 88:1461\u20131467. https:\/\/doi.org\/10.1212\/WNL.0000000000003810","journal-title":"Neurology"},{"key":"10809_CR12","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/mds.27811","volume":"34","author":"JS Perlmutter","year":"2019","unstructured":"Perlmutter JS, Stoessl AJ (2019) Striatal DAT SPECT: caveat emptor! Mov Disord 34:1430\u20131432. https:\/\/doi.org\/10.1002\/mds.27811","journal-title":"Mov Disord"},{"key":"10809_CR13","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/ene.12444","volume":"21","author":"F Brigo","year":"2014","unstructured":"Brigo F, Matinella A, Erro R, Tinazzi M (2014) [123I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson\u2019s disease and vascular or drug-induced parkinsonisms: a meta-analysis. Eur J Neurol 21:1369-e90. https:\/\/doi.org\/10.1111\/ene.12444","journal-title":"Eur J Neurol"},{"key":"10809_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40035-017-0076-6","volume":"6","author":"U Saeed","year":"2017","unstructured":"Saeed U, Compagnone J, Aviv RI et al (2017) Imaging biomarkers in Parkinson\u2019s disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener 6:8. https:\/\/doi.org\/10.1186\/s40035-017-0076-6","journal-title":"Transl Neurodegener"},{"key":"10809_CR15","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/mds.10482","volume":"18","author":"HTS Benamer","year":"2003","unstructured":"Benamer HTS, Oertel WH, Patterson J et al (2003) Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3\u00a0month observations. Mov Disord 18:977\u2013984. https:\/\/doi.org\/10.1002\/mds.10482","journal-title":"Mov Disord"},{"key":"10809_CR16","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1056\/NEJMoa033447","volume":"351","author":"S Fahn","year":"2004","unstructured":"Fahn S, Oakes D, Shoulson I et al (2004) Levodopa and the progression of Parkinson\u2019s disease. N Engl J Med 351:2498\u20132508. https:\/\/doi.org\/10.1056\/NEJMoa033447","journal-title":"N Engl J Med"},{"key":"10809_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","unstructured":"Parkinson Progression Marker Initiative (2011) The Parkinson progression marker initiative (PPMI). Prog Neurobiol 95:629\u2013635. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005","journal-title":"Prog Neurobiol"},{"key":"10809_CR18","doi-asserted-by":"publisher","first-page":"iv37","DOI":"10.1007\/s00415-005-4008-5","volume":"252","author":"Fahn S, Group and the PS","year":"2005","unstructured":"Fahn S, Group and the PS (2005) Does levodopa slow or hasten the rate of progression of Parkinson\u2019s disease? J Neurol 252:iv37\u2013iv42. https:\/\/doi.org\/10.1007\/s00415-005-4008-5","journal-title":"J Neurol"},{"key":"10809_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ana.10609","volume":"54","author":"AL Whone","year":"2003","unstructured":"Whone AL, Watts RL, Stoessl AJ et al (2003) Slower progression of Parkinson\u2019s disease with ropinirole versus levodopa: the REAL-PET study. Ann Neurol 54:93\u2013101. https:\/\/doi.org\/10.1002\/ana.10609","journal-title":"Ann Neurol"},{"key":"10809_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jnnp-2014-310256","volume":"87","author":"R Erro","year":"2016","unstructured":"Erro R, Schneider SA, Stamelou M et al (2016) What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies. J Neurol Neurosurg Psychiatry 87:319\u2013323. https:\/\/doi.org\/10.1136\/jnnp-2014-310256","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10809_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1212\/WNL.0000000000000821","volume":"83","author":"R Cilia","year":"2014","unstructured":"Cilia R, Reale C, Castagna A et al (2014) Novel DYT11 gene mutation in patients without dopaminergic deficit (SWEDD) screened for dystonia. Neurology 83:1155\u20131162. https:\/\/doi.org\/10.1212\/WNL.0000000000000821","journal-title":"Neurology"},{"key":"10809_CR22","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1007\/s00415-014-7477-6","volume":"261","author":"AD Rosa","year":"2014","unstructured":"Rosa AD, Carducci C, Carducci C et al (2014) Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD). J Neurol 261:2204\u20132208. https:\/\/doi.org\/10.1007\/s00415-014-7477-6","journal-title":"J Neurol"},{"key":"10809_CR23","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/mds.21685","volume":"22","author":"SA Schneider","year":"2007","unstructured":"Schneider SA, Edwards MJ, Mir P et al (2007) Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 22:2210\u20132215. https:\/\/doi.org\/10.1002\/mds.21685","journal-title":"Mov Disord"},{"key":"10809_CR24","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/mds.23019","volume":"25","author":"P Schwingenschuh","year":"2010","unstructured":"Schwingenschuh P, Ruge D, Edwards MJ et al (2010) Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson\u2019s disease: a clinical and electrophysiological study. Mov Disord 25:560\u2013569. https:\/\/doi.org\/10.1002\/mds.23019","journal-title":"Mov Disord"},{"key":"10809_CR25","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/mds.25171","volume":"27","author":"MT C\u00e1ceres-Redondo","year":"2012","unstructured":"C\u00e1ceres-Redondo MT, Carrillo F, Palomar FJ, Mir P (2012) DYT-1 gene dystonic tremor presenting as a \u201cscan without evidence of dopaminergic deficit.\u201d Mov Disord 27:1469\u20131469. https:\/\/doi.org\/10.1002\/mds.25171","journal-title":"Mov Disord"},{"key":"10809_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/mds.24040","volume":"27","author":"KF de Laat","year":"2012","unstructured":"de Laat KF, van de Warrenburg BP (2012) Re-emergent tremor in a dystonic SWEDD case. Mov Disord 27:462\u2013463. https:\/\/doi.org\/10.1002\/mds.24040","journal-title":"Mov Disord"},{"key":"10809_CR27","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/mds.25102","volume":"27","author":"H Stockner","year":"2012","unstructured":"Stockner H, Schwingenschuh P, Djamshidian A et al (2012) Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson\u2019s disease? Mov Disord 27:1182\u20131185. https:\/\/doi.org\/10.1002\/mds.25102","journal-title":"Mov Disord"},{"key":"10809_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG et al (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 15:503\u2013510","journal-title":"Mov Disord"},{"key":"10809_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s002590000460","volume":"28","author":"J Booij","year":"2001","unstructured":"Booij J, Speelman JD, Horstink MWIM, Wolters EC (2001) The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 28:266\u2013272. https:\/\/doi.org\/10.1007\/s002590000460","journal-title":"Eur J Nucl Med"},{"key":"10809_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/mds.21185","volume":"22","author":"T Eckert","year":"2007","unstructured":"Eckert T, Feigin A, Lewis DE et al (2007) Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging. Mov Disord 22:167\u2013173. https:\/\/doi.org\/10.1002\/mds.21185","journal-title":"Mov Disord"},{"key":"10809_CR31","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1001\/archneur.61.8.1224","volume":"61","author":"DL Jennings","year":"2004","unstructured":"Jennings DL, Seibyl JP, Oakes D et al (2004) (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 61:1224\u20131229. https:\/\/doi.org\/10.1001\/archneur.61.8.1224","journal-title":"Arch Neurol"},{"key":"10809_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mds.22108","volume":"24","author":"VL Marshall","year":"2009","unstructured":"Marshall VL, Reininger CB, Marquardt M et al (2009) Parkinson\u2019s disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3\u00a0year European multicenter study with repeat [123I]FP-CIT SPECT. Mov Disord 24:500\u2013508. https:\/\/doi.org\/10.1002\/mds.22108","journal-title":"Mov Disord"},{"key":"10809_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S0212-6982(09)70207-1","volume":"28","author":"J Serrano Vicente","year":"2009","unstructured":"Serrano Vicente J, Garc\u00eda Bernardo L, Dur\u00e1n Barquero C et al (2009) Valor predictivo negativo del SPECT con Ioflupano 123I en los trastornos del movimiento. Rev Esp Med Nucl 28:2\u20135. https:\/\/doi.org\/10.1016\/S0212-6982(09)70207-1","journal-title":"Rev Esp Med Nucl"},{"key":"10809_CR34","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00415-011-6076-z","volume":"258","author":"F Sixel-D\u00f6ring","year":"2011","unstructured":"Sixel-D\u00f6ring F, Liepe K, Mollenhauer B et al (2011) The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol 258:2147\u20132154. https:\/\/doi.org\/10.1007\/s00415-011-6076-z","journal-title":"J Neurol"},{"key":"10809_CR35","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00415-012-6495-5","volume":"259","author":"NPS Bajaj","year":"2012","unstructured":"Bajaj NPS, Wang L, Gontu V et al (2012) Accuracy of subjective and objective handwriting assessment for differentiating Parkinson\u2019s disease from tremulous subjects without evidence of dopaminergic deficits (SWEDDs): an FP-CIT-validated study. J Neurol 259:2335\u20132340. https:\/\/doi.org\/10.1007\/s00415-012-6495-5","journal-title":"J Neurol"},{"key":"10809_CR36","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1590\/S0004-282X2012000900004","volume":"70","author":"MAT Utiumi","year":"2012","unstructured":"Utiumi MAT, Fel\u00edcio AC, Borges CR et al (2012) Dopamine transporter imaging in clinically unclear cases of parkinsonism and the importance of scans without evidence of dopaminergic deficit (SWEDDs). Arq Neuropsiquiatr 70:667\u2013673. https:\/\/doi.org\/10.1590\/S0004-282X2012000900004","journal-title":"Arq Neuropsiquiatr"},{"key":"10809_CR37","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.0000000000000424","volume":"82","author":"K Marek","year":"2014","unstructured":"Marek K, Seibyl J, Eberly S et al (2014) Longitudinal follow-up of SWEDD subjects in the PRECEPT study. Neurology 82:1791\u20131797. https:\/\/doi.org\/10.1212\/WNL.0000000000000424","journal-title":"Neurology"},{"key":"10809_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00056","author":"M Men\u00e9ndez-Gonz\u00e1lez","year":"2014","unstructured":"Men\u00e9ndez-Gonz\u00e1lez M, Tavares F, Zeidan N et al (2014) Diagnoses behind patients with hard-to-classify tremor and normal DaT-SPECT: a clinical follow up study. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2014.00056","journal-title":"Front Aging Neurosci"},{"key":"10809_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fneur.2018.00335","volume":"9","author":"M Men\u00e9ndez-Gonz\u00e1lez","year":"2018","unstructured":"Men\u00e9ndez-Gonz\u00e1lez M, \u00c1lvarez-Avell\u00f3n T, Salas-Pacheco JM et al (2018) Frontotemporal lobe degeneration as origin of scans without evidence of dopaminergic deficit. Front Neurol 9:335. https:\/\/doi.org\/10.3389\/fneur.2018.00335","journal-title":"Front Neurol"},{"key":"10809_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246881","volume":"16","author":"JW Lee","year":"2021","unstructured":"Lee JW, Song YS, Kim H et al (2021) Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson\u2019s disease: analysis of the PPMI data. PLoS ONE 16:e0246881. https:\/\/doi.org\/10.1371\/journal.pone.0246881","journal-title":"PLoS ONE"},{"key":"10809_CR41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1477-7819-11-224","volume":"11","author":"S Badzek","year":"2013","unstructured":"Badzek S, Miletic V, Prejac J et al (2013) Paraneoplastic stiff person syndrome associated with colon cancer misdiagnosed as idiopathic Parkinson\u2019s disease worsened after capecitabine therapy. World J Surg Oncol 11:224. https:\/\/doi.org\/10.1186\/1477-7819-11-224","journal-title":"World J Surg Oncol"},{"key":"10809_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/mdc3.12089","volume":"2","author":"S Jakobson Mo","year":"2015","unstructured":"Jakobson Mo S, Linder J, Forsgren L, Riklund K (2015) Accuracy of visual assessment of dopamine transporter imaging in early parkinsonism. Mov Disord Clin Pract 2:17\u201323. https:\/\/doi.org\/10.1002\/mdc3.12089","journal-title":"Mov Disord Clin Pract"},{"key":"10809_CR43","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1017\/S1041610216001101","volume":"28","author":"AP Hermida","year":"2016","unstructured":"Hermida AP, Janjua AU, Glass OM et al (2016) A case of lithium-induced parkinsonism presenting with typical motor symptoms of Parkinson\u2019s disease in a bipolar patient. Int Psychogeriatr 28:2101\u20132104. https:\/\/doi.org\/10.1017\/S1041610216001101","journal-title":"Int Psychogeriatr"},{"key":"10809_CR44","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1212\/WNL.0b013e3181a18809","volume":"72","author":"PG Bain","year":"2009","unstructured":"Bain PG (2009) Dystonic tremor presenting as parkinsonism: long term follow-up of SWEDD. Neurology 72:1443\u20131445. https:\/\/doi.org\/10.1212\/WNL.0b013e3181a18809","journal-title":"Neurology"},{"key":"10809_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.parkreldis.2018.07.012","volume":"57","author":"D-Y Kwon","year":"2018","unstructured":"Kwon D-Y, Kwon Y, Kim J-W (2018) Quantitative analysis of finger and forearm movements in patients with off state early stage Parkinson\u2019s disease and scans without evidence of dopaminergic deficit (SWEDD). Parkinsonism Relat Disord 57:33\u201338. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.07.012","journal-title":"Parkinsonism Relat Disord"},{"key":"10809_CR46","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1002\/mds.23684","volume":"26","author":"OS Mian","year":"2011","unstructured":"Mian OS, Schneider SA, Schwingenschuh P et al (2011) Gait in SWEDDs patients: comparison with Parkinson\u2019s disease patients and healthy controls. Mov Disord 26:1266\u20131273. https:\/\/doi.org\/10.1002\/mds.23684","journal-title":"Mov Disord"},{"key":"10809_CR47","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.4103\/0366-6999.159352","volume":"128","author":"H-G Zheng","year":"2015","unstructured":"Zheng H-G, Zhang R, Li X et al (2015) Heterogeneity of monosymptomatic resting tremor in a prospective study: clinical features, electrophysiological test, and dopamine transporter positron emission tomography. Chin Med J (Engl) 128:1765\u20131771. https:\/\/doi.org\/10.4103\/0366-6999.159352","journal-title":"Chin Med J (Engl)"},{"key":"10809_CR48","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3233\/JPD-202090","volume":"10","author":"SR Suwijn","year":"2020","unstructured":"Suwijn SR, Samim H, Eggers C et al (2020) Value of clinical signs in identifying patients with scans without evidence of dopaminergic deficit (SWEDD). J Park Dis 10:1561\u20131569. https:\/\/doi.org\/10.3233\/JPD-202090","journal-title":"J Park Dis"},{"key":"10809_CR49","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1136\/jnnp.2009.193391","volume":"81","author":"NPS Bajaj","year":"2010","unstructured":"Bajaj NPS, Gontu V, Birchall J et al (2010) Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry 81:1223\u20131228. https:\/\/doi.org\/10.1136\/jnnp.2009.193391","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10809_CR50","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10072-012-1244-1","volume":"34","author":"W Jang","year":"2013","unstructured":"Jang W, Kim J-S, Cho JW et al (2013) Cardiac sympathetic denervation in Parkinson\u2019s disease patients with SWEDDs. Neurol Sci 34:1375\u20131382. https:\/\/doi.org\/10.1007\/s10072-012-1244-1","journal-title":"Neurol Sci"},{"key":"10809_CR51","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.parkreldis.2014.09.024","volume":"20","author":"H-J Yang","year":"2014","unstructured":"Yang H-J, Kim YE, Yun JY et al (2014) Comparison of sleep and other non-motor symptoms between SWEDDs patients and de novo Parkinson\u2019s disease patients. Parkinsonism Relat Disord 20:1419\u20131422. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.09.024","journal-title":"Parkinsonism Relat Disord"},{"key":"10809_CR52","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3233\/JPD-201944","volume":"10","author":"L Jackson","year":"2020","unstructured":"Jackson L, Turcano P, Stitt D et al (2020) Autonomic testing profiles in scans without evidence of dopaminergic deficit (SWEDD). J Park Dis 10:945\u2013949. https:\/\/doi.org\/10.3233\/JPD-201944","journal-title":"J Park Dis"},{"key":"10809_CR53","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3233\/JPD-160874","volume":"6","author":"Y-S Oh","year":"2016","unstructured":"Oh Y-S, Choi JH, Kwon D-Y (2016) Classification of scans without evidence of dopamine deficit (SWEDD) according to the olfactory function. J Park Dis 6:771\u2013778. https:\/\/doi.org\/10.3233\/JPD-160874","journal-title":"J Park Dis"},{"key":"10809_CR54","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.26204","volume":"30","author":"FS Sprenger","year":"2015","unstructured":"Sprenger FS, Seppi K, Djamshidian A et al (2015) Nonmotor symptoms in subjects without evidence of dopaminergic deficits. Mov Disord 30:976\u2013981. https:\/\/doi.org\/10.1002\/mds.26204","journal-title":"Mov Disord"},{"key":"10809_CR55","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mds.26456","volume":"31","author":"S Taylor","year":"2016","unstructured":"Taylor S, Gafton J, Shah B et al (2016) Progression of nonmotor symptoms in subgroups of patients with non\u2013dopamine-deficient Parkinsonism. Mov Disord 31:344\u2013351. https:\/\/doi.org\/10.1002\/mds.26456","journal-title":"Mov Disord"},{"key":"10809_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/8898887","volume":"2021","author":"Z Kurlawala","year":"2021","unstructured":"Kurlawala Z, Shadowen PH, McMillan JD et al (2021) Progression of nonmotor symptoms in Parkinson\u2019s disease by sex and motor laterality. Park Dis 2021:1\u201312. https:\/\/doi.org\/10.1155\/2021\/8898887","journal-title":"Park Dis"},{"key":"10809_CR57","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024837","volume":"100","author":"Z Yu","year":"2021","unstructured":"Yu Z, Li Y (2021) Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit. Medicine (Baltimore) 100:e24837. https:\/\/doi.org\/10.1097\/MD.0000000000024837","journal-title":"Medicine (Baltimore)"},{"key":"10809_CR58","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/WNN.0000000000000107","volume":"29","author":"KA Wyman-Chick","year":"2016","unstructured":"Wyman-Chick KA, Martin PK, Min\u00e1r M, Schroeder RW (2016) Cognition in patients with a clinical diagnosis of Parkinson disease and scans without evidence of dopaminergic deficit (SWEDD): 2\u00a0year follow-up. Cogn Behav Neurol 29:190\u2013196. https:\/\/doi.org\/10.1097\/WNN.0000000000000107","journal-title":"Cogn Behav Neurol"},{"key":"10809_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1017\/S1355617718000164","volume":"24","author":"KA Wyman-Chick","year":"2018","unstructured":"Wyman-Chick KA, Martin PK, Min\u00e1r M et al (2018) Neuropsychological test performance in parkinsonism without dopaminergic deficiency on [123I]-FP-CIT SPECT imaging. J Int Neuropsychol Soc 24:646\u2013651. https:\/\/doi.org\/10.1017\/S1355617718000164","journal-title":"J Int Neuropsychol Soc"},{"key":"10809_CR60","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1002\/mds.26344","volume":"30","author":"L Silveira-Moriyama","year":"2015","unstructured":"Silveira-Moriyama L, Birchall J, Bain P et al (2015) Hyposmia in SWEDD: letter to the editors. Mov Disord 30:1436\u20131437. https:\/\/doi.org\/10.1002\/mds.26344","journal-title":"Mov Disord"},{"key":"10809_CR61","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fneur.2020.00364","volume":"11","author":"C Leger","year":"2020","unstructured":"Leger C, Herbert M, DeSouza JFX (2020) Non-motor clinical and biomarker predictors enable high cross-validated accuracy detection of early PD but lesser cross-validated accuracy detection of scans without evidence of dopaminergic deficit. Front Neurol 11:364. https:\/\/doi.org\/10.3389\/fneur.2020.00364","journal-title":"Front Neurol"},{"key":"10809_CR62","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1007\/s11307-020-01502-y","volume":"22","author":"N Nicastro","year":"2020","unstructured":"Nicastro N, Burkhard PR, Garibotto V (2020) Preserved extrastriatal 123I-FP-CIT binding in scans without evidence of dopaminergic deficit (SWEDD). Mol Imaging Biol 22:1592\u20131599. https:\/\/doi.org\/10.1007\/s11307-020-01502-y","journal-title":"Mol Imaging Biol"},{"key":"10809_CR63","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1186\/s40064-016-3110-8","volume":"5","author":"M Kim","year":"2016","unstructured":"Kim M, Park H (2016) Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson\u2019s disease patients. Springerplus 5:1421. https:\/\/doi.org\/10.1186\/s40064-016-3110-8","journal-title":"Springerplus"},{"key":"10809_CR64","doi-asserted-by":"publisher","first-page":"8704910","DOI":"10.1155\/2016\/8704910","volume":"2016","author":"M Kim","year":"2016","unstructured":"Kim M, Park H (2016) Using tractography to distinguish SWEDD from Parkinson\u2019s disease patients based on connectivity. Park Dis 2016:8704910. https:\/\/doi.org\/10.1155\/2016\/8704910","journal-title":"Park Dis"},{"key":"10809_CR65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.bbr.2018.09.003","volume":"356","author":"L Jin","year":"2019","unstructured":"Jin L, Zeng Q, He J et al (2019) A ReliefF-SVM-based method for marking dopamine-based disease characteristics: a study on SWEDD and Parkinson\u2019s disease. Behav Brain Res 356:400\u2013407. https:\/\/doi.org\/10.1016\/j.bbr.2018.09.003","journal-title":"Behav Brain Res"},{"key":"10809_CR66","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neuroscience.2020.03.049","volume":"435","author":"Y Feng","year":"2020","unstructured":"Feng Y, Yan W, Wang J et al (2020) Local white matter fiber clustering differentiates Parkinson\u2019s disease diagnoses. Neuroscience 435:146\u2013160. https:\/\/doi.org\/10.1016\/j.neuroscience.2020.03.049","journal-title":"Neuroscience"},{"key":"10809_CR67","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1017\/cjn.2015.385","volume":"43","author":"S-J Kang","year":"2016","unstructured":"Kang S-J, Ahn JY, Kim J-S et al (2016) 24-hour ambulatory blood pressure monitoring in SWEDDs patients With parkinsonism. Can J Neurol Sci 43:390\u2013397. https:\/\/doi.org\/10.1017\/cjn.2015.385","journal-title":"Can J Neurol Sci"},{"key":"10809_CR68","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jns.2017.01.042","volume":"375","author":"F Yoshii","year":"2017","unstructured":"Yoshii F, Ryo M, Baba Y et al (2017) Combined use of dopamine transporter imaging (DAT-SPECT) and 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson\u2019s disease. J Neurol Sci 375:80\u201385. https:\/\/doi.org\/10.1016\/j.jns.2017.01.042","journal-title":"J Neurol Sci"},{"key":"10809_CR69","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awv215","volume":"138","author":"Z Qamhawi","year":"2015","unstructured":"Qamhawi Z, Towey D, Shah B et al (2015) Clinical correlates of raphe serotonergic dysfunction in early Parkinson\u2019s disease. Brain 138:2964\u20132973. https:\/\/doi.org\/10.1093\/brain\/awv215","journal-title":"Brain"},{"key":"10809_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2016.03.023","volume":"28","author":"T Schirinzi","year":"2016","unstructured":"Schirinzi T, Di Lorenzo F, Ponzo V et al (2016) Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD). Parkinsonism Relat Disord 28:23\u201328. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.03.023","journal-title":"Parkinsonism Relat Disord"},{"key":"10809_CR71","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/01.mnm.0000243374.11260.5b","volume":"27","author":"VL Marshall","year":"2006","unstructured":"Marshall VL, Patterson J, Hadley DM et al (2006) Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nucl Med Commun 27:933\u2013937. https:\/\/doi.org\/10.1097\/01.mnm.0000243374.11260.5b","journal-title":"Nucl Med Commun"},{"key":"10809_CR72","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/mds.26018","volume":"29","author":"A Batla","year":"2014","unstructured":"Batla A, Erro R, Stamelou M et al (2014) Patients with scans without evidence of dopaminergic deficit: a long-term follow-up study. Mov Disord 29:1820\u20131825. https:\/\/doi.org\/10.1002\/mds.26018","journal-title":"Mov Disord"},{"key":"10809_CR73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00019442-200201000-00005","volume":"10","author":"CH van Dyck","year":"2002","unstructured":"van Dyck CH, Seibyl JP, Malison RT et al (2002) Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. Am J Geriatr Psychiatry 10:36\u201343","journal-title":"Am J Geriatr Psychiatry"},{"key":"10809_CR74","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/ana.20226","volume":"56","author":"GW Ross","year":"2004","unstructured":"Ross GW, Petrovitch H, Abbott RD et al (2004) Parkinsonian signs and substantia nigra neuron density in decendents elders without PD. Ann Neurol 56:532\u2013539. https:\/\/doi.org\/10.1002\/ana.20226","journal-title":"Ann Neurol"},{"key":"10809_CR75","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.parkreldis.2016.07.002","volume":"31","author":"N Nicastro","year":"2016","unstructured":"Nicastro N, Garibotto V, Badoud S, Burkhard PR (2016) Scan without evidence of dopaminergic deficit: a 10\u00a0year retrospective study. Parkinsonism Relat Disord 31:53\u201358. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.07.002","journal-title":"Parkinsonism Relat Disord"},{"key":"10809_CR76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jns.2017.11.039","volume":"385","author":"N Nicastro","year":"2018","unstructured":"Nicastro N, Burkhard PR, Garibotto V (2018) Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: a prospective study. J Neurol Sci 385:17\u201321. https:\/\/doi.org\/10.1016\/j.jns.2017.11.039","journal-title":"J Neurol Sci"},{"key":"10809_CR77","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/mds.26450","volume":"31","author":"DJ Wile","year":"2016","unstructured":"Wile DJ, Dinelle K, Vafai N et al (2016) A scan without evidence is not evidence of absence: scans without evidence of dopaminergic deficit in a symptomatic leucine-rich repeat kinase 2 mutation carrier. Mov Disord 31:405\u2013409. https:\/\/doi.org\/10.1002\/mds.26450","journal-title":"Mov Disord"},{"key":"10809_CR78","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/mds.26705","volume":"31","author":"V Garibotto","year":"2016","unstructured":"Garibotto V, Nicastro N, Burkhard PR (2016) No more SWEDDs. Mov Disord 31:1426\u20131426. https:\/\/doi.org\/10.1002\/mds.26705","journal-title":"Mov Disord"},{"key":"10809_CR79","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/mds.28019","volume":"35","author":"A Garrido","year":"2020","unstructured":"Garrido A, Iranzo A, Stefani A et al (2020) Lack of asymmetry of nigrostriatal dopaminergic function in healthy subjects. Mov Disord 35:1072\u20131076. https:\/\/doi.org\/10.1002\/mds.28019","journal-title":"Mov Disord"},{"key":"10809_CR80","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/jnnp-2015-310756","volume":"87","author":"H Ling","year":"2016","unstructured":"Ling H, Kearney S, Yip HLK et al (2016) Parkinson\u2019s disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)? J Neurol Neurosurg Psychiatry 87:633\u2013641. https:\/\/doi.org\/10.1136\/jnnp-2015-310756","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10809_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018301","author":"R Cilia","year":"2011","unstructured":"Cilia R, Rossi C, Frosini D et al (2011) Dopamine transporter SPECT imaging in corticobasal syndrome. PLoS\u00a0One. https:\/\/doi.org\/10.1371\/journal.pone.0018301","journal-title":"PLoS\u00a0One"},{"key":"10809_CR82","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00415-013-6886-2","volume":"260","author":"V Kaasinen","year":"2013","unstructured":"Kaasinen V, Gardberg M, R\u00f6ytt\u00e4 M et al (2013) Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration. J Neurol 260:1410\u20131411. https:\/\/doi.org\/10.1007\/s00415-013-6886-2","journal-title":"J Neurol"},{"key":"10809_CR83","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.parkreldis.2014.04.022","volume":"20","author":"J McKinley","year":"2014","unstructured":"McKinley J, O\u2019Connell M, Farrell M, Lynch T (2014) Normal dopamine transporter imaging does not exclude multiple system atrophy. Parkinsonism Relat Disord 20:933\u2013934. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.04.022","journal-title":"Parkinsonism Relat Disord"},{"key":"10809_CR84","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1002\/mds.22323","volume":"23","author":"SS O\u2019Sullivan","year":"2008","unstructured":"O\u2019Sullivan SS, Burn DJ, Holton JL, Lees AJ (2008) Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration. Mov Disord 23:2424\u20132426. https:\/\/doi.org\/10.1002\/mds.22323","journal-title":"Mov Disord"},{"key":"10809_CR85","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1007\/s00259-016-3312-x","volume":"43","author":"JJ van der Zande","year":"2016","unstructured":"van der Zande JJ, Booij J, Scheltens P et al (2016) [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies. Eur J Nucl Med Mol Imaging 43:1060\u20131066. https:\/\/doi.org\/10.1007\/s00259-016-3312-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10809_CR86","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1007\/s00415-012-6643-y","volume":"259","author":"M Kolenc","year":"2012","unstructured":"Kolenc M, Popovi\u0107 M, Grmek M et al (2012) A case of multiple system atrophy with normal dopamine transporter imaging. J Neurol 259:2729\u20132731. https:\/\/doi.org\/10.1007\/s00415-012-6643-y","journal-title":"J Neurol"},{"key":"10809_CR87","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1007\/s00415-011-6108-8","volume":"258","author":"E Mu\u00f1oz","year":"2011","unstructured":"Mu\u00f1oz E, Iranzo A, Rauek S et al (2011) Subclinical nigrostriatal dopaminergic denervation in the cerebellar subtype of multiple system atrophy (MSA-C). J Neurol 258:2248\u20132253. https:\/\/doi.org\/10.1007\/s00415-011-6108-8","journal-title":"J Neurol"},{"key":"10809_CR88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.parkreldis.2019.02.006","volume":"63","author":"S Vergnet","year":"2019","unstructured":"Vergnet S, Hives F, Foubert-Samier A et al (2019) Dopamine transporter imaging for the diagnosis of multiple system atrophy cerebellar type. Parkinsonism Relat Disord 63:199\u2013203. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.02.006","journal-title":"Parkinsonism Relat Disord"},{"key":"10809_CR89","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1007\/s00415-012-6774-1","volume":"260","author":"M Aguirregomozcorta","year":"2013","unstructured":"Aguirregomozcorta M, Stamelou M, Antonini A et al (2013) Patients with rest-tremor and scans with ipsilateral dopaminergic deficit. J Neurol 260:1132\u20131135. https:\/\/doi.org\/10.1007\/s00415-012-6774-1","journal-title":"J Neurol"},{"key":"10809_CR90","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/mds.26202","volume":"30","author":"E Hoshiyama","year":"2015","unstructured":"Hoshiyama E, Kadowaki T, Nakamura A et al (2015) The decreasing of dopamine-transporter uptake on the right ipsilateral side of tremor in a patient with Parkinson\u2019s disease [abstract]. Mov Disord 30:996","journal-title":"Mov Disord"},{"key":"10809_CR91","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/acn3.268","volume":"3","author":"V Kaasinen","year":"2015","unstructured":"Kaasinen V (2015) Ipsilateral deficits of dopaminergic neurotransmission in Parkinson\u2019s disease. Ann Clin Transl Neurol 3:21\u201326. https:\/\/doi.org\/10.1002\/acn3.268","journal-title":"Ann Clin Transl Neurol"},{"key":"10809_CR92","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s00415-013-7030-z","volume":"260","author":"R Erro","year":"2013","unstructured":"Erro R, Barone P, Vicidomini C et al (2013) Patients with Parkinson\u2019s disease and scans with (predominant) ipsilateral dopaminergic deficit. J Neurol 260:2405\u20132406. https:\/\/doi.org\/10.1007\/s00415-013-7030-z","journal-title":"J Neurol"},{"key":"10809_CR93","doi-asserted-by":"publisher","first-page":"13924","DOI":"10.1523\/JNEUROSCI.1648-14.2014","volume":"34","author":"T Tazoe","year":"2014","unstructured":"Tazoe T, Perez MA (2014) Selective activation of ipsilateral motor pathways in intact humans. J Neurosci 34:13924\u201313934. https:\/\/doi.org\/10.1523\/JNEUROSCI.1648-14.2014","journal-title":"J Neurosci"},{"key":"10809_CR94","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.expneurol.2008.01.024","volume":"211","author":"SD Tabbal","year":"2008","unstructured":"Tabbal SD, Ushe M, Mink JW et al (2008) Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Exp Neurol 211:234\u2013242. https:\/\/doi.org\/10.1016\/j.expneurol.2008.01.024","journal-title":"Exp Neurol"},{"key":"10809_CR95","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/ana.10517","volume":"53","author":"JL Vitek","year":"2003","unstructured":"Vitek JL, Bakay RAE, Freeman A et al (2003) Randomized trial of pallidotomy versus medical therapy for Parkinson\u2019s disease. Ann Neurol 53:558\u2013569. https:\/\/doi.org\/10.1002\/ana.10517","journal-title":"Ann Neurol"},{"key":"10809_CR96","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1212\/WNL.0b013e318253d5dd","volume":"78","author":"M Kojovic","year":"2012","unstructured":"Kojovic M, Bologna M, Kassavetis P et al (2012) Functional reorganization of sensorimotor cortex in early Parkinson disease. Neurology 78:1441\u20131448. https:\/\/doi.org\/10.1212\/WNL.0b013e318253d5dd","journal-title":"Neurology"},{"key":"10809_CR97","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2967\/jnmt.113.126078","volume":"42","author":"AK Janicek","year":"2014","unstructured":"Janicek AK, Avery RJ, Kuo PH (2014) The pinwheel sign: artifact from head rotation during SPECT acquisition for dopamine transporter imaging. J Nucl Med Technol 42:75\u201376. https:\/\/doi.org\/10.2967\/jnmt.113.126078","journal-title":"J Nucl Med Technol"},{"key":"10809_CR98","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2967\/jnmt.112.117184","volume":"41","author":"MF Covington","year":"2013","unstructured":"Covington MF, McMillan NA, Avery RJ, Kuo PH (2013) The semicolon sign: dopamine transporter imaging artifact from head tilt. J Nucl Med Technol 41:105\u2013107. https:\/\/doi.org\/10.2967\/jnmt.112.117184","journal-title":"J Nucl Med Technol"},{"key":"10809_CR99","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1212\/WNL.0b013e318289709d","volume":"80","author":"R Erro","year":"2013","unstructured":"Erro R, Pappat\u00e0 S, Picillo M et al (2013) Teaching neuroimages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism. Neurology 80:e147\u2013e147. https:\/\/doi.org\/10.1212\/WNL.0b013e318289709d","journal-title":"Neurology"},{"key":"10809_CR100","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s00259-007-0621-0","volume":"35","author":"J Booij","year":"2008","unstructured":"Booij J, Kemp P (2008) Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs. Eur J Nucl Med Mol Imaging 35:424\u2013438. https:\/\/doi.org\/10.1007\/s00259-007-0621-0","journal-title":"Eur J Nucl Med Mol Imaging"}],"updated-by":[{"DOI":"10.1007\/s00415-021-10923-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000}}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10809-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10809-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10809-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T15:19:16Z","timestamp":1642778356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10809-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10809"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10809-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00415-021-10923-w","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,18]]},"assertion":[{"value":"26 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2021","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00415-021-10923-w","URL":"https:\/\/doi.org\/10.1007\/s00415-021-10923-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RB declares no conflict of interest. PB received consultancies as a member of the advisory board for Zambon, Lundbeck, UCB, Chiesi, Abbvie, and Acorda. FM is Editor-in-Chief of the Journal of Neurology and Associate Editor of Radiology, Human Brain Mapping and Neurological Sciences, received compensation for consulting services and\/or speaking activities from Almiral, Alexion, Bayer, Biogen, Celgene, Eli Lilly, Genzyme, Merck-Serono, Novartis, Roche, Sanofi, Takeda, and Teva Pharmaceutical Industries, and receives research support from Biogen Idec, Merck-Serono, Novartis and Roche. RE received royalties from the publication of \u201cParoxysmal Movement Disorders\u201d (Springer, 2020) and honoraria for speaking from the Movement Disorder Society.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}